Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 10, 2013, Pages

  D'Agostino, Dominic P ^a   Pilla, Raffaele ^a   Held, Heather E ^a   Landon, Carol S ^a   Puchowicz, Michelle ^b   Brunengraber, Henri ^b   Ari, Csilla ^a   Arnold, Patrick ^c   Dean, Jay B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Savind Inc   (United States)

Author keywords

Acetoacetate; Acetone; Epilepsy; Hyperbaric oxygen; Ketogenic diet

Indexed keywords

1,3 BUTANEDIOL ACETOACETATE DIESTER; 3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ACETONE; GLUCOSE; KETONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON DIOXIDE TENSION; CENTRAL NERVOUS SYSTEM OXYGEN TOXICITY SEIZURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HYPERBARIC OXYGEN; KETOACIDOSIS; LATENT PERIOD; MALE; NONHUMAN; OXYGEN TENSION; PH; PRIORITY JOURNAL; RAT; SEIZURE; SINGLE DRUG DOSE; TELEMETRY;

ACETOACETATE; ACETONE; EPILEPSY; HYPERBARIC OXYGEN; KETOGENIC DIET;

ACETOACETATES; ANIMALS; BLOOD GLUCOSE; BRAIN; BUTYLENE GLYCOLS; ELECTROENCEPHALOGRAPHY; KETOSIS; MALE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TELEMETRY;

EID: 84878652279     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00506.2012     Document Type: Article

References (55)

1. Beckman DL, Crittenden DJ, Overton DH, 3rd, Blumenthal SJ. Influence of blood glucose on convulsive seizures from hyperbaric oxygen. Life Sci 31: 45-49, 1982.
2. Bielohuby M, Menhofer D, Kirchner H, Stoehr BJ, Muller TD, Stock P, Hempel M, Stemmer K, Pfluger PT, Kienzle E, Christ B, Tschop MH, Bidlingmaier M. Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am J Physiol Endocrinol Metab 300: E65-E76, 2011.
3. Bitterman N, Katz A. The effect of sodium phenytoin on central nervous system oxygen toxicity. Aviat Space Environ Med 58: 224-226, 1987.
4. Bitterman N, Skapa E, Gutterman A. Starvation and dehydration attenuate CNS oxygen toxicity in rats. Brain Res 761: 146-150, 1997.
5. Bough KJ, Gudi K, Han FT, Rathod AH, Eagles DA. An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res 50: 313-325, 2002.
6. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48: 43-58, 2007.
7. Brunengraber H. Potential of ketone body esters for parenteral and oral nutrition. Nutrition 13: 233-235, 1997.
8. Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr 26: 1-22, 2006.
9. Chavko M, Braisted JC, Harabin AL. Attenuation of brain hyperbaric oxygen toxicity by fasting is not related to ketosis. Undersea Hyperb Med 26: 99-103, 1999.
10. Chavko M, Braisted JC, Harabin AL. Effect of MK-801 on seizures induced by exposure to hyperbaric oxygen: comparison with AP-7. Toxicol Appl Pharmacol 151: 222-228, 1998.
11. Chavko M, Xing G, Keyser DO. Increased sensitivity to seizures in repeated exposures to hyperbaric oxygen: role of NOS activation. Brain Res 900: 227-233, 2001.
12. Ciraolo ST, Previs SF, Fernandez CA, Agarwal KC, David F, Koshy J, Lucas D, Tammaro A, Stevens MP, Tserng KY. Model of extreme hypoglycemia in dogs made ketotic with (R,S)-1,3-butanediol acetoacetate esters. Am J Physiol Endocrinol Metab 269: E67-E75, 1995.
13. Clark JM, Thom SR. Toxicity of oxygen, carbon dioxide, and carbon monoxide. In: Bove and Davis' Diving Medicine (3rd ed.), edited by Bove AA. Philadelphia, PA: Saunders, 1997, p. 131-145.
14. Clarke K, Tchabanenko K, Pawlosky R, Carter E, Knight NS, Murray AJ, Cochlin LE, King MT, Wong AW, Roberts A, Robertson J, Veech RL. Oral 28-day and developmental toxicity studies of (R)-3- hydroxybutyl (R)-3-hydroxybutyrate. Regul Toxicol Pharmacol 63: 196-208, 2012.
15. Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, Ho M, Roberts A, Robertson J, Vanitallie TB, Veech RL. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63: 401-408, 2012.
16. D'Agostino D, Bennett A, Kesl S, Diamond D, Dean J. Ketones reduce superoxide production in cultured U87 cells and hippocampal neurons: implications for metabolic therapy in cancer and CNS oxygen toxicity. FASEB J 25: 832.7, 2011.
17. D'Agostino DP, McNally HA, Dean JB. Development and testing of hyperbaric atomic force microscopy (AFM) and fluorescence microscopy for biological applications. J Microsc 246: 129-142, 2012.
18. D'Agostino DP, Olson JE, Dean JB. Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells. Neuroscience 159: 1011-1022, 2009.
19. D'Agostino DP, Putnam RW, Dean JB. Superoxide production in CA1 neurons of rat hippocampal slices exposed to graded levels of oxygen. J Neurophysiol 98: 1030-1041, 2007.
20. Demchenko IT, Dmitriy AN, Boso AE, Astern J, PLH, Piantadosi CA. Oxygen seizure latency and peroxynitrite formation in mice lacking neuronal or endothelial nitric oxide synthases. Neurosci Lett 344: 53-56, 2003.
21. Desrochers S, Dubreuil P, Brunet J, Jette M, David F, Landau BR, Brunengraber H. Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs. Am J Physiol Endocrinol Metab 268: E660-E667, 1995.
22. Freeman JM, Kossoff EH. Ketosis and the ketogenic diet: advances in treating epilepsy and other disorders. Adv Pediatr 57: 315-329, 2010.
23. Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 48: 793-800, 2007.
24. Gerschman R, Gilbert DL, Nye SW. Oxygen poisoning and x-irradiation: a mechanism in common. Science 119: 623-626, 1954.
25. Greene AE, Todorova MT, Seyfried TN. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 86: 529-537, 2003.
26. Habib MP, Dickerson F, Mooradian AD. Ethane production rate in vivo is reduced with dietary restriction. J Appl Physiol 68: 2588-2590, 1990.
27. Henderson ST. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics 5: 470-480, 2008.
28. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y. Metabolic control of vesicular glutamate transport and release. Neuron 68: 99-112, 2010.
29. Kim do Y, Vallejo J, Rho JM. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem 114: 130-141, 2010.
30. Klein P, Janousek J, Barber A, Weissberger R. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav 19: 575-579, 2010.
31. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism- based therapies. Curr Opin Neurol 25: 173-178, 2012.
32. Likhodii S, Nylen K, Burnham WM. Acetone as an anticonvulsant. Epilepsia 49, Suppl 8: 83-86, 2008.
33. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC, 3rd, Burnham WM. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 54: 219-226, 2003.
34. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 59: 293-315, 2009.
35. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145: 256-264, 2007.
36. McNally MA, Hartman AL. Ketone bodies in epilepsy. J Neurochem 121: 28-35, 2011.
37. Milder JB, Liang LP, Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 40: 238-244, 2010.
38. +-sensitive neurons in rat brain stem slices. J Appl Physiol 95: 910-921, 2003.
39. Nylen K, Likhodii SS, Hum KM, Burnham WM. A ketogenic diet and diallyl sulfide do not elevate afterdischarge thresholds in adult kindled rats. Epilepsy Res 71: 23-31, 2006.
40. Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 28: 1-16, 2008.
41. Puchowicz MA, Smith CL, Bomont C, Koshy J, David F, Brunengraber H. Dog model of therapeutic ketosis induced by oral administration of R,S-1,3-butanediol diacetoacetate. J Nutr Biochem 11: 281-287, 2000.
42. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in L-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43: 358-361, 2002.
43. Rho JM, Sankar R. The ketogenic diet in a pill: is this possible? Epilepsia 49, Suppl 8: 127-133, 2008.
44. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 9: 651-658, 1995.
45. Seymour KJ, Bluml S, Sutherling J, Sutherling W, Ross BD. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA 8: 33-42, 1999.
46. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3: 59, 2012.
47. Tate RL, Mehlman MA, Tobin RB. Metabolic fate of 1,3-butanediol in the rat: conversion to -hydroxybutyrate. J Nutr 101: 1719-1726, 1971.
48. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 334: 1642-1648, 1996.
49. Torbati D, Greenberg J, Lambertsen CJ. Correlation of brain glucose utilization and cortical electrical activity during development of brain oxygen toxicity. Brain Res 262: 267-273, 1983.
50. Tzuk-Shina T, Bitterman N, Harel D. The effect of vigabatrin on central nervous system oxygen toxicity in rats. Eur J Pharmacol 202: 171-175, 1991.
51. VanItallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutr Rev 61: 327-341, 2003.
52. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70: 309-319, 2004.
53. Veech RL, Kashiwaya Y, Gates DN, King MT, Clarke K. The energetics of ion distribution: the origin of the resting electric potential of cells. IUBMB Life 54: 241-252, 2002.
54. Withrow CD. The ketogenic diet: mechanism of anticonvulsant action. Adv Neurol 27: 635-642, 1980.
55. Yellen G. Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet. Epilepsia 49, Suppl 8: 80-82, 2008.